June 9, 2014

Merck and Idenix Pharmaceuticals on Monday announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.

July 25, 2011

A phrase like “silent killer” sounds creepy enough on its own, but it’s an often-used one for a virus that, according to the Centers for Disease Control and Prevention, infects 1.3% to 1.9% of people in the United States.


June 24, 2010

The Food and Drug Administration has approved a new rapid blood test for detecting hepatitis...

June 9, 2010

Idenix Pharmaceuticals has started a proof-of-concept study of an investigational drug for hepatitis C currently...

March 1, 2010

The market for hepatitis C drugs could get a boost if a clinical trial program...